{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:50:46Z","timestamp":1778939446143,"version":"3.51.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T00:00:00Z","timestamp":1398988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12015-014-9514-3","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T02:01:45Z","timestamp":1398909705000},"page":"573-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Human Wharton's Jelly Stem Cells, its Conditioned Medium and Cell-Free Lysate Inhibit the Growth of Human Lymphoma Cells"],"prefix":"10.1007","volume":"10","author":[{"given":"Hao Daniel","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chui Yee","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arijit","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Choolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariff","family":"Bongso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,2]]},"reference":[{"key":"9514_CR1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbio.200910072","volume":"2","author":"C Lo Celso","year":"2009","unstructured":"Lo Celso, C., Wu, J. W., & Lin, C. P. (2009). In vivo imaging of hematopoietic stem cells and their microenvironment. Journal of Biophotonics, 2, 619\u201331.","journal-title":"Journal of Biophotonics"},{"key":"9514_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4161\/cib.2.4.8222","volume":"2","author":"JM Gillette","year":"2009","unstructured":"Gillette, J. M., & Lippincott-Schwartz, J. (2009). Hematopoietic progenitor cells regulate their niche microenvironment through a novel mechanism of cell-cell communication. Communications Integrative Biology, 2, 305\u20137.","journal-title":"Communications Integrative Biology"},{"key":"9514_CR3","doi-asserted-by":"crossref","first-page":"e26241","DOI":"10.1371\/journal.pone.0026241","volume":"6","author":"S Carrancio","year":"2011","unstructured":"Carrancio, S., Blanco, B., Romo, C., Muntion, S., Lopez-Holgado, N., Blanco, J. F., et al. (2011). Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: Effect on bone marrow microenvironment. PLoS ONE, 6, e26241.","journal-title":"PLoS ONE"},{"key":"9514_CR4","doi-asserted-by":"crossref","first-page":"e31741","DOI":"10.1371\/journal.pone.0031741","volume":"7","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Chen, X. H., Si, Y. J., Li, Z. J., Gao, L., Gao, L., et al. (2012). Reconstruction of hematopoietic inductive microenvironment after transplantation of VCAM-1-modified human umbilical cord blood stromal cells. PLoS ONE, 7, e31741.","journal-title":"PLoS ONE"},{"key":"9514_CR5","first-page":"207","volume":"15","author":"E O'Flaherty","year":"1995","unstructured":"O'Flaherty, E., Sparrow, R., & Szer, J. (1995). Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplantation, 15, 207\u201312.","journal-title":"Bone Marrow Transplantation"},{"key":"9514_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0162-3109(99)00168-X","volume":"46","author":"I Guest","year":"2000","unstructured":"Guest, I., & Uetrecht, J. (2000). Drugs toxic to the bone marrow that target the stromal cells. Immunopharmacology, 46, 103\u201312.","journal-title":"Immunopharmacology"},{"key":"9514_CR7","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1210\/jc.2002-020800","volume":"87","author":"L Tauchmanova","year":"2002","unstructured":"Tauchmanova, L., Serio, B., Del Puente, A., Risitano, A. M., Esposito, A., De Rosa, G., et al. (2002). Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. Journal of Clinical Endocrinology and Metabolism, 87, 5058\u201365.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"9514_CR8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00277-009-0896-2","volume":"89","author":"K Kemp","year":"2010","unstructured":"Kemp, K., Morse, R., Wexler, S., Cox, C., Mallam, E., Hows, J., et al. (2010). Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy. Annals of Hematology, 89, 701\u201313.","journal-title":"Annals of Hematology"},{"key":"9514_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/157488808783489462","volume":"3","author":"V Fritz","year":"2008","unstructured":"Fritz, V., & Jorgensen, C. (2008). Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Current Stem Cell Research & Therapy, 3, 32\u201342.","journal-title":"Current Stem Cell Research & Therapy"},{"key":"9514_CR10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/mt.2009.62","volume":"17","author":"DJ Prockop","year":"2009","unstructured":"Prockop, D. J. (2009). Repair of tissues by adult stem\/progenitor cells (MSCs): controversies, myths, and changing paradigms. Molecular Therapy, 17, 939\u201346.","journal-title":"Molecular Therapy"},{"key":"9514_CR11","first-page":"459510","volume":"2011","author":"RS Wong","year":"2011","unstructured":"Wong, R. S. (2011). Mesenchymal stem cells: angels or demons? Journal of Biomedicine and Biotechnology, 2011, 459510.","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"9514_CR12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s000180050322","volume":"55","author":"GJ Maestroni","year":"1999","unstructured":"Maestroni, G. J., Hertens, E., & Galli, P. (1999). Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cellular and Molecular Life Sciences, 55, 663\u20137.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"9514_CR13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yexmp.2003.06.001","volume":"75","author":"LB Ohlsson","year":"2003","unstructured":"Ohlsson, L. B., Varas, L., Kjellman, C., Edvardsen, K., & Lindvall, M. (2003). Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Experimental and Molecular Pathology, 75, 248\u201355.","journal-title":"Experimental and Molecular Pathology"},{"key":"9514_CR14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","volume":"203","author":"AY Khakoo","year":"2006","unstructured":"Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., et al. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. Journal of Experimental Medicine, 203, 1235\u201347.","journal-title":"Journal of Experimental Medicine"},{"key":"9514_CR15","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-04-3770","volume":"65","author":"S Jodele","year":"2005","unstructured":"Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., et al. (2005). The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Research, 65, 3200\u20138.","journal-title":"Cancer Research"},{"key":"9514_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/scrt221","volume":"4","author":"T Zhang","year":"2013","unstructured":"Zhang, T., Lee, Y. W., Rui, Y. F., Cheng, T. Y., Jiang, X. H., & Li, G. (2013). Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Research Therapy, 4, 70.","journal-title":"Stem Cell Research Therapy"},{"key":"9514_CR17","first-page":"174","volume":"39","author":"A Cardone","year":"1997","unstructured":"Cardone, A., Tolino, A., Zarcone, R., Borruto Caracciolo, G., & Tartaglia, E. (1997). Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Medica, 39, 174\u20137.","journal-title":"Panminerva Medica"},{"key":"9514_CR18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","volume":"1","author":"MJ Bissell","year":"2001","unstructured":"Bissell, M. J., & Radisky, D. (2001). Putting tumours in context. Nature Reviews Cancer, 1, 46\u201354.","journal-title":"Nature Reviews Cancer"},{"key":"9514_CR19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.coi.2005.01.008","volume":"17","author":"T Blankenstein","year":"2005","unstructured":"Blankenstein, T. (2005). The role of tumor stroma in the interaction between tumor and immune system. Current Opinion in Immunology, 17, 180\u20136.","journal-title":"Current Opinion in Immunology"},{"key":"9514_CR20","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/0008-5472.CAN-08-0943","volume":"68","author":"PJ Mishra","year":"2008","unstructured":"Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., et al. (2008). Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Research, 68, 4331\u20139.","journal-title":"Cancer Research"},{"key":"9514_CR21","doi-asserted-by":"crossref","first-page":"e4992","DOI":"10.1371\/journal.pone.0004992","volume":"4","author":"EL Spaeth","year":"2009","unstructured":"Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., et al. (2009). Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE, 4, e4992.","journal-title":"PLoS ONE"},{"key":"9514_CR22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S1472-6483(10)60539-1","volume":"15","author":"CY Fong","year":"2007","unstructured":"Fong, C. Y., Richards, M., Manasi, N., Biswas, A., & Bongso, A. (2007). Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reproductive Biomedicine Online, 15, 708\u201318.","journal-title":"Reproductive Biomedicine Online"},{"key":"9514_CR23","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood-2007-07-099333","volume":"111","author":"XY Wang","year":"2008","unstructured":"Wang, X. Y., Lan, Y., He, W. Y., Zhang, L., Yao, H. Y., Hou, C. M., et al. (2008). Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. Blood, 111, 2436\u201343.","journal-title":"Blood"},{"key":"9514_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.rbmo.2010.04.010","volume":"21","author":"CY Fong","year":"2010","unstructured":"Fong, C. Y., Subramanian, A., Biswas, A., Gauthaman, K., Srikanth, P., Hande, M. P., et al. (2010). Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reproductive Biomedicine Online, 21, 391\u2013401.","journal-title":"Reproductive Biomedicine Online"},{"key":"9514_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.rbmo.2011.10.007","volume":"24","author":"K Gauthaman","year":"2012","unstructured":"Gauthaman, K., Fong, C. Y., Suganya, C. A., Subramanian, A., Biswas, A., Choolani, M., et al. (2012). Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. Reproductive Biomedicine Online, 24, 235\u201346.","journal-title":"Reproductive Biomedicine Online"},{"key":"9514_CR26","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/scd.2011.0441","volume":"21","author":"Y Wang","year":"2012","unstructured":"Wang, Y., Han, Z. B., Ma, J., Zuo, C., Geng, J., Gong, W., et al. (2012). A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Stem Cells and Development, 21, 1401\u20138.","journal-title":"Stem Cells and Development"},{"key":"9514_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cellimm.2012.03.012","volume":"276","author":"H Chen","year":"2012","unstructured":"Chen, H., Zhang, N., Li, T., Guo, J., Wang, Z., Yang, M., et al. (2012). Human umbilical cord Wharton's jelly stem cells: immune property genes assay and effect of transplantation on the immune cells of heart failure patients. Cellular Immunology, 276, 83\u201390.","journal-title":"Cellular Immunology"},{"key":"9514_CR28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/TP.0b013e31827a93dd","volume":"95","author":"KH Wu","year":"2013","unstructured":"Wu, K. H., Sheu, J. N., Wu, H. P., Tsai, C., Sieber, M., Peng, C. T., et al. (2013). Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study. Transplantation, 95, 773\u2013777.","journal-title":"Transplantation"},{"key":"9514_CR29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.cgt.7701077","volume":"14","author":"RS Rachakatla","year":"2007","unstructured":"Rachakatla, R. S., Marini, F., Weiss, M. L., Tamura, M., & Troyer, D. (2007). Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Therapy, 14, 828\u201335.","journal-title":"Cancer Gene Therapy"},{"key":"9514_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2009.02.011","volume":"280","author":"R Ayuzawa","year":"2009","unstructured":"Ayuzawa, R., Doi, C., Rachakatla, R. S., Pyle, M. M., Maurya, D. K., Troyer, D., et al. (2009). Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Letters, 280, 31\u20137.","journal-title":"Cancer Letters"},{"key":"9514_CR31","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/0008-5472.CAN-08-2750","volume":"69","author":"C Ganta","year":"2009","unstructured":"Ganta, C., Chiyo, D., Ayuzawa, R., Rachakatla, R., Pyle, M., Andrews, G., et al. (2009). Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100\u00a0days post-tumor cell inoculation. Cancer Research, 69, 1815\u201320.","journal-title":"Cancer Research"},{"key":"9514_CR32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/1471-2407-10-590","volume":"10","author":"DK Maurya","year":"2010","unstructured":"Maurya, D. K., Doi, C., Kawabata, A., Pyle, M. M., King, C., Wu, Z., et al. (2010). Therapy with un-engineered naive rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma. BMC Cancer, 10, 590.","journal-title":"BMC Cancer"},{"key":"9514_CR33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2010.04.007","volume":"296","author":"B Sun","year":"2010","unstructured":"Sun, B., Yu, K. R., Bhandari, D. R., Jung, J. W., Kang, S. K., & Kang, K. S. (2010). Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation. Cancer Letters, 296, 178\u201385.","journal-title":"Cancer Letters"},{"issue":"2","key":"9514_CR34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10549-011-1774-x","volume":"133","author":"Y Ma","year":"2011","unstructured":"Ma, Y., Hao, X., Zhang, S., & Zhang, J. (2011). The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Research and Treatment, 133(2), 473\u201385.","journal-title":"Breast Cancer Research and Treatment"},{"key":"9514_CR35","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/j.1582-4934.2011.01459.x","volume":"16","author":"KC Chao","year":"2012","unstructured":"Chao, K. C., Yang, H. T., & Chen, M. W. (2012). Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalization. Journal of Cellular and Molecular Medicine, 16, 1803\u201315.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9514_CR36","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/jcb.24073","volume":"113","author":"K Gauthaman","year":"2012","unstructured":"Gauthaman, K., Fong, C. Y., Cheyyatraivendran, S., Biswas, A., Choolani, M., & Bongso, A. (2012). Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. Journal of Cellular Biochemistry, 113, 2027\u201339.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9514_CR37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcb.24367","volume":"114","author":"K Gauthaman","year":"2013","unstructured":"Gauthaman, K., Fong, C. Y., Arularasu, S., Subramanian, A., Biswas, A., Choolani, M., et al. (2013). Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice. Journal of Cellular Biochemistry, 114, 366\u201377.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9514_CR38","doi-asserted-by":"crossref","first-page":"e62844","DOI":"10.1371\/journal.pone.0062844","volume":"8","author":"J Liu","year":"2013","unstructured":"Liu, J., Han, G., Liu, H., & Qin, C. (2013). Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling. PLoS ONE, 8, e62844.","journal-title":"PLoS ONE"},{"key":"9514_CR39","doi-asserted-by":"crossref","first-page":"e61366","DOI":"10.1371\/journal.pone.0061366","volume":"8","author":"S Wu","year":"2013","unstructured":"Wu, S., Ju, G. Q., Du, T., Zhu, Y. J., & Liu, G. H. (2013). Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS ONE, 8, e61366.","journal-title":"PLoS ONE"},{"key":"9514_CR40","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jcb.24057","volume":"113","author":"A Subramanian","year":"2012","unstructured":"Subramanian, A., Shu-Uin, G., Kae-Siang, N., Gauthaman, K., Biswas, A., Choolani, M., et al. (2012). Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells. Journal of Cellular Biochemistry, 113, 1886\u201395.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9514_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/scd.2009.0177","volume":"19","author":"U Nekanti","year":"2010","unstructured":"Nekanti, U., Rao, V. B., Bahirvani, A. G., Jan, M., Totey, S., & Ta, M. (2010). Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells and Development, 19, 117\u201330.","journal-title":"Stem Cells and Development"},{"key":"9514_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-010-9166-x","volume":"7","author":"CY Fong","year":"2011","unstructured":"Fong, C. Y., Chak, L. L., Biswas, A., Tan, J. H., Gauthaman, K., Chan, W. K., et al. (2011). Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Reviews, 7, 1\u201316.","journal-title":"Stem Cell Reviews"},{"key":"9514_CR43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jcyt.2013.01.006","volume":"15","author":"A Kawabata","year":"2013","unstructured":"Kawabata, A., Ohta, N., Seiler, G., Pyle, M. M., Ishiguro, S., Zhang, Y. Q., et al. (2013). Naive rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses. Cytotherapy, 15, 586\u201397.","journal-title":"Cytotherapy"},{"key":"9514_CR44","doi-asserted-by":"crossref","first-page":"e11140","DOI":"10.1371\/journal.pone.0011140","volume":"5","author":"P Secchiero","year":"2010","unstructured":"Secchiero, P., Zorzet, S., Tripodo, C., Corallini, F., Melloni, E., Caruso, L., et al. (2010). Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS ONE, 5, e11140.","journal-title":"PLoS ONE"},{"key":"9514_CR45","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1042\/CBI20110595","volume":"36","author":"M Fonseka","year":"2012","unstructured":"Fonseka, M., Ramasamy, R., Yip, W. K., Tan, B. C., & Seow, H. F. (2012). Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (Human erythromyeloblastoid leukemic cell line). Cell Biology Intnl, 36, 793\u2013801.","journal-title":"Cell Biology Intnl"},{"key":"9514_CR46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcb.23395","volume":"113","author":"CY Fong","year":"2012","unstructured":"Fong, C. Y., Gauthaman, K., Cheyyatraivendran, S., Lin, H. D., Biswas, A., & Bongso, A. (2012). Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. Journal of Cellular Biochemistry, 113, 658\u201368.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9514_CR47","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/jcmm.12095","volume":"17","author":"HT Yang","year":"2013","unstructured":"Yang, H. T., & Chao, K. C. (2013). Foetal defence against cancer: a hypothesis. Journal of Cellular and Molecular Medicine, 17, 1096\u20138.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9514_CR48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/1097-0142(197002)25:2<380::AID-CNCR2820250216>3.0.CO;2-Q","volume":"25","author":"JF Potter","year":"1970","unstructured":"Potter, J. F., & Schoeneman, M. (1970). Metastasis of maternal cancer to the placenta and fetus. Cancer, 25, 380\u20138.","journal-title":"Cancer"},{"key":"9514_CR49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006254-198907000-00008","volume":"44","author":"GA Dildy 3rd","year":"1989","unstructured":"Dildy, G. A., 3rd, Moise, K. J., Jr., Carpenter, R. J., Jr., & Klima, T. (1989). Maternal malignancy metastatic to the products of conception: a review. Obstetrical and Gynecological Survey, 44, 535\u201340.","journal-title":"Obstetrical and Gynecological Survey"},{"key":"9514_CR50","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","volume":"21","author":"A Alexander","year":"2003","unstructured":"Alexander, A., Samlowski, W. E., Grossman, D., Bruggers, C. S., Harris, R. M., Zone, J. J., et al. (2003). Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. Journal of Clinical Oncology, 21, 2179\u201386.","journal-title":"Journal of Clinical Oncology"},{"key":"9514_CR51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00404-002-0356-x","volume":"268","author":"C Jackisch","year":"2003","unstructured":"Jackisch, C., Louwen, F., Schwenkhagen, A., Karbowski, B., Schmid, K. W., Schneider, H. P., et al. (2003). Lung cancer during pregnancy involving the products of conception and a review of the literature. Archives of Gynecology and Obstetrics, 268, 69\u201377.","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"9514_CR52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ygyno.2006.08.007","volume":"103","author":"J Liu","year":"2006","unstructured":"Liu, J., & Guo, L. (2006). Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: a case report and review of the literature. Gynecologic Oncology, 103, 1147\u201351.","journal-title":"Gynecologic Oncology"},{"key":"9514_CR53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0923-2494(99)80037-6","volume":"149","author":"F Henry","year":"1998","unstructured":"Henry, F., Bretaudeau, L., Barbieux, K., Meflah, K., & Gregoire, M. (1998). Induction of antigen presentation by macrophages after phagocytosis of tumorapoptotic cells. Research in Immunology, 149, 673\u20139.","journal-title":"Research in Immunology"},{"key":"9514_CR54","doi-asserted-by":"crossref","unstructured":"Chan J, Harrison JS, Ponzio NM, Rameshwar P. Mesenchymal stem cells (MSC) exhibit antigen presenting (APC) and phagocytic properties: Implications to bone marrow failure during inflammation. Blood 104: Abstract 4249.","DOI":"10.1182\/blood.V104.11.4249.4249"},{"key":"9514_CR55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2249.2002.01774.x","volume":"127","author":"RN Barker","year":"2002","unstructured":"Barker, R. N., Erwig, L. P., Hill, K. S., Devine, A., Pearce, W. P., & Rees, A. J. (2002). Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells. Clinical and Experimental Immunology, 127, 220\u20135.","journal-title":"Clinical and Experimental Immunology"},{"key":"9514_CR56","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","volume":"26","author":"ML Weiss","year":"2008","unstructured":"Weiss, M. L., Anderson, C., Medicetty, S., Seshareddy, K. B., Weiss, R. J., & Vanderwerff, I. (2008). Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells, 26, 2865\u20132874.","journal-title":"Stem Cells"},{"key":"9514_CR57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.1987.tb06866.x","volume":"65","author":"M Bewick","year":"1987","unstructured":"Bewick, M., Coutie, W., & Tudhope, G. R. (1987). Superoxide dismutase, glutathione peroxidase and catalase in the red cells of patients with malignant lymphoma. British Journal of Haematology, 65, 347\u201350.","journal-title":"British Journal of Haematology"},{"key":"9514_CR58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/15230860152409095","volume":"3","author":"LW Oberley","year":"2001","unstructured":"Oberley, L. W. (2001). Anticancer therapy by overexpression of superoxide dismutase. Antioxidants and Redox Signaling, 3, 461\u201372.","journal-title":"Antioxidants and Redox Signaling"},{"key":"9514_CR59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cccn.2003.08.013","volume":"338","author":"N Bakan","year":"2003","unstructured":"Bakan, N., Taysi, S., Yilmaz, O., Bakan, E., Kuskay, S., Uzun, N., et al. (2003). Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clinica Chimica Acta, 338, 143\u20139.","journal-title":"Clinica Chimica Acta"},{"key":"9514_CR60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/07357900902849665","volume":"28","author":"R Davicino","year":"2010","unstructured":"Davicino, R., Manuele, M. G., Turner, S., Ferraro, G., & Anesini, C. (2010). Antiproliferative activity of Larrea divaricata Cav. on lymphoma cell line: participation of hydrogen peroxide in its action. Cancer Investigation, 28, 13\u201322.","journal-title":"Cancer Investigation"},{"key":"9514_CR61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.onc.1200852","volume":"14","author":"W Zhong","year":"1997","unstructured":"Zhong, W., Oberley, L. W., Oberley, T. D., & St Clair, D. K. (1997). Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene, 14, 481\u201390.","journal-title":"Oncogene"},{"key":"9514_CR62","first-page":"1175","volume":"7","author":"W Zhong","year":"1996","unstructured":"Zhong, W., Oberley, L. W., Oberley, T. D., Yan, T., Domann, F. E., & St Clair, D. K. (1996). Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells. Cell Growth and Differentiation, 7, 1175\u201386.","journal-title":"Cell Growth and Differentiation"},{"key":"9514_CR63","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.freeradbiomed.2011.09.002","volume":"51","author":"ME Tome","year":"2011","unstructured":"Tome, M. E., Jaramillo, M. C., & Briehl, M. M. (2011). Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells. Free Radical Biology and Medicine, 51, 2048\u201359.","journal-title":"Free Radical Biology and Medicine"},{"key":"9514_CR64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3892\/etm.2012.595","volume":"4","author":"ME Tome","year":"2012","unstructured":"Tome, M. E., Lee, K., Jaramillo, M. C., & Briehl, M. M. (2012). Mitochondria are the primary source of the H(2)O(2) signal for glucocorticoid-induced apoptosis of lymphoma cells. Experiment Therapeutica Medicine, 4, 237\u2013242.","journal-title":"Experiment Therapeutica Medicine"},{"key":"9514_CR65","unstructured":"Vogelzang NJ. 1991. Nephrotoxicity from chemotherapy: prevention and management. Oncology (Williston Park) 5:97-102, 105; disc 105, 109-11."},{"key":"9514_CR66","first-page":"477","volume":"2","author":"CH Takimoto","year":"1996","unstructured":"Takimoto, C. H., Lu, Z. H., Zhang, R., Liang, M. D., Larson, L. V., Cantilena, L. R., Jr., et al. (1996). Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clinical Cancer Research, 2, 477\u201381.","journal-title":"Clinical Cancer Research"},{"key":"9514_CR67","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","volume":"49","author":"G Takemura","year":"2007","unstructured":"Takemura, G., & Fujiwara, H. (2007). Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Progress in Cardiovascular Diseases, 49, 330\u201352.","journal-title":"Progress in Cardiovascular Diseases"},{"key":"9514_CR68","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/14653249.2011.646044","volume":"14","author":"GH Di","year":"2012","unstructured":"Di, G. H., Jiang, S., Li, F. Q., Sun, J. Z., Wu, C. T., Hu, X., et al. (2012). Human umbilical cord mesenchymal stromal cells mitigate chemotherapy-associated tissue injury in a pre-clinical mouse model. Cytotherapy, 14, 412\u201322.","journal-title":"Cytotherapy"},{"key":"9514_CR69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood.V44.3.385.385","volume":"44","author":"W Chamberlin","year":"1974","unstructured":"Chamberlin, W., Barone, J., Kedo, A., & Fried, W. (1974). Lack of recovery of murine hematopoietic stromal cells after irradiation-induced damage. Blood, 44, 385\u201392.","journal-title":"Blood"},{"key":"9514_CR70","first-page":"108","volume":"10","author":"NS Wolf","year":"1982","unstructured":"Wolf, N. S. (1982). Dissecting the hematopoietic microenvironment. V: limitations of repair following damage to the hematopoietic support stroma. Experimental Hematology, 10, 108\u201318.","journal-title":"Experimental Hematology"},{"key":"9514_CR71","first-page":"122","volume":"3","author":"LF Gibson","year":"1997","unstructured":"Gibson, L. F., Fortney, J., Landreth, K. S., Piktel, D., Ericson, S. G., & Lynch, J. P. (1997). Disruption of bone marrow stromal cell function by etoposide. Biology of Blood and Marrow Transplantation, 3, 122\u201332.","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"9514_CR72","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0301-472X(99)00076-4","volume":"27","author":"M Galotto","year":"1999","unstructured":"Galotto, M., Berisso, G., Delfino, L., Podesta, M., Ottaggio, L., Dallorso, S., et al. (1999). Stromal damage as consequence of high-dose chemo\/radiotherapy in bone marrow transplant recipients. Experimental Hematology, 27, 1460\u20136.","journal-title":"Experimental Hematology"},{"key":"9514_CR73","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbmt.2007.08.048","volume":"13","author":"R Friedman","year":"2007","unstructured":"Friedman, R., Betancur, M., Boissel, L., Tuncer, H., Cetrulo, C., & Klingemann, H. (2007). Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biology of Blood and Marrow Transplantation, 13, 1477\u201386.","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"9514_CR74","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","volume":"21","author":"K Blanc Le","year":"2007","unstructured":"Le Blanc, K., Samuelsson, H., Gustafsson, B., Remberger, M., Sundberg, B., Arvidson, J., et al. (2007). Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia, 21, 1733\u20138.","journal-title":"Leukemia"},{"key":"9514_CR75","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/bmt.2013.7","volume":"48","author":"SH Lee","year":"2013","unstructured":"Lee, S. H., Lee, M. W., Yoo, K. H., Kim, D. S., Son, M. H., Sung, K. W., et al. (2013). Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation. Bone Marrow Transplantation, 48, 1040\u20135.","journal-title":"Bone Marrow Transplantation"},{"key":"9514_CR76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12015-010-9168-8","volume":"7","author":"CG Fan","year":"2011","unstructured":"Fan, C. G., Zhang, Q., & Zhou, J. (2011). Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Reviews and Reports, 7, 195\u2013207.","journal-title":"Stem Cell Reviews and Reports"},{"key":"9514_CR77","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/bmt.2010.305","volume":"46","author":"YH Chao","year":"2011","unstructured":"Chao, Y. H., Tsai, C., Peng, C. T., Wu, H. P., Chan, C. K., Weng, T., et al. (2011). Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplantation, 46, 1391\u20132.","journal-title":"Bone Marrow Transplantation"},{"key":"9514_CR78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","volume":"60","author":"J Hu","year":"2013","unstructured":"Hu, J., Yu, X., Wang, Z., Wang, F., Wang, L., Gao, H., et al. (2013). Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocrine Journal, 60, 347\u201357.","journal-title":"Endocrine Journal"},{"key":"9514_CR79","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/pr.2011.67","volume":"71","author":"J Dalous","year":"2012","unstructured":"Dalous, J., Larghero, J., & Baud, O. (2012). Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatric Research, 71, 482\u201390.","journal-title":"Pediatric Research"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-014-9514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12015-014-9514-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-014-9514-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:48:20Z","timestamp":1648918100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12015-014-9514-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,2]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9514"],"URL":"https:\/\/doi.org\/10.1007\/s12015-014-9514-3","relation":{},"ISSN":["1550-8943","1558-6804"],"issn-type":[{"value":"1550-8943","type":"print"},{"value":"1558-6804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,2]]}}}